Exciting Announcement from LENSAR
LENSAR, Inc. (NASDAQ: LNSR), a pioneering medical technology firm specializing in advanced robotic laser solutions for cataract treatment, has recently made headlines with an important announcement. The Chief Executive Officer, Nick Curtis, will engage with investors during a fireside chat at the BTIG 4th Annual Ophthalmology Day. This event is scheduled to take place soon, providing a unique platform for interaction with institutional investors.
Details of the Event
The highly anticipated event will host Nick Curtis on December 2, 2024, at 2 p.m. ET. In addition to the fireside chat, LENSAR management plans to conduct one-on-one meetings with institutional investors, offering them an exclusive opportunity to engage with the company’s leadership. This initiative is part of LENSAR's ongoing effort to strengthen its relationships with current and prospective investors.
Purpose of BTIG Events
BTIG events are designed to create a network for both prospective and existing clients. They aim to facilitate meaningful discussions around potential collaborations, investment strategies, and industry insights. Investors interested in attending the live event are encouraged to reach out to their BTIG representatives for more information.
About LENSAR and Its Innovation
LENSAR stands out in the medical technology landscape by focusing on the design, development, and marketing of innovative systems specifically tailored for cataract treatment. Their premier product, the ALLY Robotic Cataract Laser System™, is a testament to the company’s commitment to transforming surgical practices. This state-of-the-art system integrates artificial intelligence and proprietary imaging software, setting new benchmarks for cataract surgery.
ALLY Robotic Cataract Laser System™
The ALLY system offers an unprecedentedly ergonomic design that allows surgeries to be performed with remarkable efficiency, whether in a sterile operating room or an office-based surgical suite. By leveraging advanced robotic technologies, it helps to cut down operational overhead and enhances the workflow for surgical teams. Moreover, the integration of LENSAR’s proprietary Streamline software technology is pivotal in guiding surgeons towards achieving optimal patient outcomes.
Meet the LENSAR Team
LENSAR's leadership team, including industry experts and innovators, is dedicated to advancing cataract surgery's future. They actively engage in discussions with key stakeholders to ensure that LENSAR remains at the forefront of medical technology developments. Investors will have the chance to learn more about the company’s future plans and innovations during the upcoming fireside chat and meetings.
Contact Information for Investors
For investor relations inquiries, LENSAR has made the following contacts available:
Lee Roth and Cameron Radinovic
Thomas R. Staab, II, CFO
Burns McClellan for LENSAR
Reach Out
Investors can reach LENSAR via email at ir.contact@lensar.com or reach out to their representatives at Burns McClellan.
Frequently Asked Questions
What is LENSAR known for?
LENSAR is recognized for its innovative robotic laser solutions aimed at enhancing cataract surgery.
When is the BTIG Ophthalmology Day?
The BTIG 4th Annual Ophthalmology Day is scheduled for December 2, 2024.
Who will represent LENSAR at the event?
Nick Curtis, the CEO of LENSAR, will participate in a fireside chat at the event.
What opportunities will investors have?
Investors will have the chance to engage in one-on-one meetings with LENSAR management during the event.
How can investors contact LENSAR?
Investors can reach out via email at ir.contact@lensar.com.
